Abstract

.Idiopathic pulmonary fibrosis (IPF) is a progressive disease with poor prognosis with short lifespan following diagnosis as patients have limited effective treatment options. A fundamental limitation is a lack of knowledge of the underlying collagen alterations in the disease, as this could lead to better diagnostics, prognostics, and measures of treatment efficacy. While the fibroses is the primary presentation of the disease, the collagen architecture has not been well studied beyond standard histology. Here, we used several metrics based on second harmonic generation (SHG) microscopy and optical scattering measurements to characterize the subresolution collagen assembly in human IPF and normal lung tissues. Using SHG directional analysis, we found that while collagen synthesis is increased in IPF, the resulting average fibril architecture is more disordered than in normal tissue. Wavelength-dependent optical scattering measurements lead to the same conclusion, and both optical approaches are consistent with ultrastructural analysis. SHG circular dichroism revealed significant differences in the net chirality between the fibrotic and normal collagen, where the former has a more randomized helical structure. Collectively, the measurements reveal significant changes in the collagen macro/supramolecular structure in the abnormal fibrotic collagen, and we suggest these alterations can serve as biomarkers for IPF diagnosis and progression.

Highlights

  • Idiopathic pulmonary fibrosis (IPF) is a form of interstitial lung disease that is a progressive disorder characterized by unrelenting scarring and stiffening of the lungs that leads to ∼34;000 deaths each year

  • We first present an overall comparison of the collagen content in normal and IPF lung tissues

  • We note that the IPF tissue has greater coverage across the field and denser collagen accumulation in comparison to normal

Read more

Summary

Introduction

Idiopathic pulmonary fibrosis (IPF) is a form of interstitial lung disease that is a progressive disorder characterized by unrelenting scarring and stiffening of the lungs that leads to ∼34;000 deaths each year. IPF is clinically diagnosed using a combination of tests including chest x-ray, high-resolution computed tomography (HRCT), lung biopsy, and lung function tests. These techniques often lack the sensitivity and specificity needed to examine the extracellular matrix (ECM) changes and their role in IPF progression. When the classic radiographic pattern is present, IPF can be diagnosed via HRCT.[2] this pattern is not always uniquely defined due to the heterogeneity of the disease. No radiographic method can probe the Journal of Biomedical Optics

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call